CYTOFOTCPharmaceutical PreparationsFiscal year ends December 31
Altamira Therapeutics Ltd.
Financials through fiscal 2024, year ended Dec 31, 2024Last filing: 20-F on Apr 30, 2025
$0.09+0.00 (0.00%)
Close on Oct 19, 2026
Ownership
Who owns Altamira Therapeutics's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Armistice Capital, LLC | 473,870 | 9.99% | 13G (passive) amendment | Mar 31, 2025 |
| Thomas Meyer | 1,079,843 | 18.90% | 13D (active) amendment | Apr 30, 2025 |